(BIOX) Bioceres Crop Solutions - Ratings and Ratios

Exchange: NASDAQ • Country: Argentina • Currency: USD • Type: Common Stock • ISIN: KYG1117K1141

BIOX EPS (Earnings per Share)

This chart shows the EPS (Earnings per Share) of BIOX over the last 5 years for every Quarter.

BIOX Revenue

This chart shows the Revenue of BIOX over the last 5 years for every Quarter.

BIOX: Seeds, Herbicides, Insecticides, Fungicides, Fertilizers

Bioceres Crop Solutions Corp is a leading provider of innovative crop productivity solutions, operating globally across multiple segments, including Seed and Integrated Products, Crop Protection, and Crop Nutrition. The companys product portfolio encompasses a broad range of offerings, such as seed traits, germplasms, seed treatment packs, crop protection chemicals, inoculants, bio-inductors, and fertilizers, all aimed at enhancing crop yields and resilience. Notably, Bioceres has developed the HB4 drought-tolerant seed technology program, a significant innovation in the agricultural biotechnology space.

The companys global footprint spans across Argentina, Brazil, North America, Europe, the Middle East, and South America, with its headquarters located in Rosario, Argentina. This strategic presence enables Bioceres to cater to diverse agricultural markets and capitalize on emerging opportunities. As a pioneer in the agricultural biotechnology sector, Bioceres has established itself as a key player in the development and commercialization of sustainable agricultural solutions.

Analyzing the provided and , we observe that BIOX has a current price of 4.65, with its SMA20 and SMA50 indicating a short-term bullish trend. However, the SMA200 at 6.74 suggests a longer-term bearish trend. The ATR of 0.35 represents a 7.59% volatility, indicating moderate price fluctuations. From a fundamental perspective, the Market Cap stands at 252.09M USD, with a P/E ratio of 208.50 and a forward P/E of 12.08, suggesting potential for earnings growth. The RoE of 0.82 indicates relatively low profitability.

Based on the analysis of and , a forecast for BIOX can be derived. The stocks short-term bullish trend, coupled with its relatively low valuation multiples, may indicate a potential buying opportunity. However, the longer-term bearish trend and low RoE necessitate caution. A possible scenario is that BIOX may experience a short-term price appreciation, potentially reaching the 52W High of 12.91, driven by improving earnings and increasing demand for sustainable agricultural solutions. Nevertheless, investors should be cautious of the stocks volatility and monitor its ability to improve profitability.

Additional Sources for BIOX Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

BIOX Stock Overview

Market Cap in USD 274m
Sector Basic Materials
Industry Agricultural Inputs
GiC Sub-Industry Fertilizers & Agricultural Chemicals
IPO / Inception 2018-03-22

BIOX Stock Ratings

Growth Rating -40.9
Fundamental 25.4
Dividend Rating 0.0
Rel. Strength -61
Analysts 5 of 5
Fair Price Momentum 3.62 USD
Fair Price DCF 8.79 USD

BIOX Dividends

Currently no dividends paid

BIOX Growth Ratios

Growth Correlation 3m 66.7%
Growth Correlation 12m -90.7%
Growth Correlation 5y -24.9%
CAGR 5y -5.80%
CAGR/Max DD 5y -0.08
Sharpe Ratio 12m -1.92
Alpha -69.43
Beta 0.475
Volatility 65.87%
Current Volume 143k
Average Volume 20d 99.7k
What is the price of BIOX shares?
As of July 01, 2025, the stock is trading at USD 4.47 with a total of 142,969 shares traded.
Over the past week, the price has changed by -1.76%, over one month by -6.88%, over three months by -2.08% and over the past year by -59.84%.
Is Bioceres Crop Solutions a good stock to buy?
Neither. Based on ValueRay´s Fundamental Analyses, Bioceres Crop Solutions is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 25.37 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of BIOX is around 3.62 USD . This means that BIOX is currently overvalued and has a potential downside of -19.02%.
Is BIOX a buy, sell or hold?
Bioceres Crop Solutions has received a consensus analysts rating of 5.00. Therefor, it is recommend to buy BIOX.
  • Strong Buy: 4
  • Buy: 0
  • Hold: 0
  • Sell: 0
  • Strong Sell: 0
What are the forecasts for BIOX share price target?
According to our own proprietary Forecast Model, BIOX Bioceres Crop Solutions will be worth about 3.9 in July 2026. The stock is currently trading at 4.47. This means that the stock has a potential downside of -12.08%.
Issuer Target Up/Down from current
Wallstreet Target Price 7.6 70.7%
Analysts Target Price 7.6 70.7%
ValueRay Target Price 3.9 -12.1%